Abstract Herpesviruses establish lifelong latency and can reactivate when antiviral immune surveillance is compromised. Since the onset of COVID-19 pandemic, reactivation of multiple human herpesviruses has increasingly been documented, particularly in patients with severe or critical illness. Herpesvirus reactivation has been associated with prolonged intensive care unit stays, secondary infections, greater ventilatory support requirements, and increased mortality.
